Australia's Nova Eye Medical rises on EU approval for glaucoma treatment

Nova Eye Medical

03/03/2026 04:25

** Shares of Nova Eye Medical EYE.AX rise as much as 3.5% to A$0.15, their biggest intraday pct gain in two weeks

** Medical tech co receives certification from European Union for commercial supply of its iTrack products in Europe

** iTrack is co's flagship surgical device that reduces reliance on anti-glaucoma medications for mild to moderate glaucoma in patients

** Stock up 13.2%, including day's moves

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))